gvtcx

28 Jul 2025 – 3 Aug 2025

week 31, 2025

1,912 notices from 830 buyers, 1,749 unique titles. 193 (10%) were open opportunities you could still bid on; 1,590 carried award details.

notices
1,912
open opportunities
193
10% of the week
median value
£160,000
largest
£4,108,145,000
excludes ceilings

biggest contracts

By stated value, excluding framework and dynamic market ceilings. Those are spending limits rather than contract values and would otherwise fill this table.

who won what

suppliercontractvalue
Dr.Reddy's Laboratories (UK) Limited NHS Branded Medicines Tranche B - MAE & NOFE - 1 September 2025 £986,282,758
Celltrion Healthcare United Kingdom Limited NHS Branded Medicines Tranche B - MAE & NOFE - 1 September 2025 £986,282,758
Abbvie Ltd NHS Branded Medicines Tranche B - MAE & NOFE - 1 September 2025 £986,282,758
Takeda UK Ltd NHS Branded Medicines Tranche B - MAE & NOFE - 1 September 2025 £986,282,758
Organon Pharmaceuticals UK Ltd NHS Branded Medicines Tranche B - MAE & NOFE - 1 September 2025 £986,282,758
Alexion Pharmaceuticals NHS Branded Medicines Tranche B - MAE & NOFE - 1 September 2025 £986,282,758
Orifarm UK NHS Branded Medicines Tranche B - MAE & NOFE - 1 September 2025 £986,282,758
CuraTeQ Biologics s.r.o. NHS Branded Medicines Tranche B - MAE & NOFE - 1 September 2025 £986,282,758
Biogen NHS Branded Medicines Tranche B - MAE & NOFE - 1 September 2025 £986,282,758
Amgen Ltd NHS Branded Medicines Tranche B - MAE & NOFE - 1 September 2025 £986,282,758
Sobi (Swedish Orphan Biovitrum Ltd) NHS Branded Medicines Tranche B - MAE & NOFE - 1 September 2025 £986,282,758
Zentiva Pharma UK Ltd NHS Branded Medicines Tranche B - MAE & NOFE - 1 September 2025 £986,282,758
Fresenius Kabi Limited NHS Branded Medicines Tranche B - MAE & NOFE - 1 September 2025 £986,282,758
Sandoz Ltd NHS Branded Medicines Tranche B - MAE & NOFE - 1 September 2025 £986,282,758
Thornton and Ross Ltd NHS Branded Medicines Tranche B - MAE & NOFE - 1 September 2025 £986,282,758